Skip To Main Content
Shrikant Barot on Muck Rack

Shrikant Barot

As seen in: MDPI, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shrikant

Contact Shrikant, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells

|
By Anjali Yadav, Himaxi Patel, Shrikant Barot, Shraddha Bhutkar
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Nanoformulation of PROteolysis TArgeting Chimera targeting ‘undruggable’ c-Myc for the treatment of pancreatic cancer

|
By Aishwarya Saraswat, Manali Patki, Yige Fu, Shrikant Barot
| Future Medicine Verified
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Open in Who Shared View Duplicates (5) Issue with article?
See all 2 articles